Nile Therapeutics Inc. lost $880,530 in the June quarter, down from a loss of $1.5 million a year earlier in the same period.
San Mateo-based Nile (Pink Sheets: NLTX) had $346,000 in revenue in the most recent quarter, compared with no revenue in the second quarter of 2010.
No comments:
Post a Comment